Clinical trial

Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

NCT00438321

Study summary

ClinicalTrials.gov

Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Zoladex Normalized identity: Zoladex View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Testosterone gel Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Anastrozole Pill Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE1

Conditions

Metabolic Syndromeverified · MONDO: abdominal obesity-metabolic syndrome

Interventions

ZoladexDRUG · verified · RxNorm: Zoladex

Testosterone gelDRUG

Anastrozole PillDRUG

PlaceboOTHER

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

National Institutes of Health (NIH)collaborator

American Diabetes Associationcollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00438321 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.